About: Advances in targeted therapies XIII

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Advances in targeted therapies XIII Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/bmj/periodical/ard/2012/volume_71
Title	Advances in targeted therapies XIII
has manifestation of work	http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_suppl2/m/print http://hub.abes.fr/bmj/periodical/ard/2012/volume_71/issue_suppl2/m/web
Date Copyrighted	2012
Rights	Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
issue	Suppl 2
is Is Part Of of	Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats HDAC inhibitor therapy in autoimmunity and transplantation Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis IL-33: a Janus cytokine Defining remission in rheumatoid arthritis CD3 ζ defects in systemic lupus erythematosus How do contemporary imaging techniques contribute to basic and clinical rheumatology? Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011 New approaches to the assessment and treatment of the idiopathic inflammatory myopathies Advances in targeted therapies XIII Roles of LAG3 and EGR2 in regulatory T cells Remission by imaging in rheumatoid arthritis: should this be the ultimate goal? In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis How to define remission in ankylosing spondylitis? TNF and EPO: major players in the innate immune response: their discovery

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata